Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Abbvie inc. source : Www.globenewswire.com save search
Coherus Presents Preclinical Data for CHS-1000, a Novel Anti-ILT4 Antibody, at the 2024 AACR Annual Meeting
Published: 2024-04-08 (Crawled : 12:30) - globenewswire.com
ABBV | News | $164.66 0.25% -0.55% 0
|
Health Technology
|
| O: 0.77%
H: 1.63%
C: 0.35%
CHRS | $2.0 -6.98% -8.04% 3.5K
|
Health Technology
|
| O: 0.82%
H: 3.88%
C: 2.45%
chs-1000 preclinical for meeting
NEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an Increase of 99.7% Year-Over-Year
Published: 2024-04-01 (Crawled : 12:00) - globenewswire.com
NXGL | News | $2.21 -2.0% -1.4% 1.1K
|
Manufacturing
|
| O: 1.83%
H: 0.0%
C: -19.42%
ABBV | News | $164.66 0.25% -0.55% 0
|
Health Technology
|
| O: -0.12%
H: 0.01%
C: -0.62%
year revenue
AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune Diseases
Published: 2024-03-25 (Crawled : 12:30) - globenewswire.com
LABP | $21.75 0.37% 0.28% 21K
|
|
| O: 176.76%
H: 0.0%
C: 0.0%
ABBV | News | $164.66 0.25% -0.55% 0
|
Health Technology
|
| O: 1.19%
H: 0.11%
C: -0.26%
abbvie acquire
Alvotech Reports Financial Results for Full Year 2023 and Provides a Business Update
Published: 2024-03-20 (Crawled : 20:00) - globenewswire.com
ALVO | $12.89 0.7% 0.78% 220
|
n/a
|
| O: -1.58%
H: 1.87%
C: 0.53%
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: -0.03%
H: 0.0%
C: 0.0%
ABBV | News | $164.66 0.25% -0.55% 0
|
Health Technology
|
| O: -0.89%
H: 0.0%
C: 0.0%
KMDA | $5.1 0.39% -0.1% 6.5K
|
Health Technology
|
| O: 0.68%
H: 0.0%
C: -1.86%
AMGN | $262.75 -0.5% -0.49% 320
|
Health Technology
|
| O: 0.58%
H: 1.2%
C: 0.84%
business year update financial results
Coherus BioSciences Reports Fourth Quarter, Full Year 2023 Financial Results and Provides Current Business Update
Published: 2024-03-13 (Crawled : 20:00) - globenewswire.com
ABBV | News | $164.66 0.25% -0.55% 0
|
Health Technology
|
| O: 0.25%
H: 0.0%
C: 0.0%
CHRS | $2.0 -6.98% -8.04% 3.5K
|
Health Technology
|
| O: -8.7%
H: 21.43%
C: 3.33%
business year update financial
U.S. FDA Accepts for Priority Review the Supplemental Biologics License Application for Epcoritamab (EPKINLY®) for Difficult-to-Treat Relapsed or Refractory Follicular Lymphoma
Published: 2024-02-27 (Crawled : 01:00) - globenewswire.com
GNMSF | $290.38 3.33% 3.83% 0
|
Health Technology
|
| O: -0.28%
H: 1.46%
C: 1.46%
ABBV | News | $164.66 0.25% -0.55% 0
|
Health Technology
|
| O: 0.13%
H: 0.0%
C: 0.0%
GMAB | $28.33 -0.7% -0.74% 360
|
Health Technology
|
| O: -1.6%
H: 1.11%
C: 0.41%
epkinly fda license review application
New Pivotal Data for Bispecific Antibody Epcoritamab (DuoBody® CD3xCD20) Demonstrates High Overall and Complete Responses in Patients with Hard-To-Treat Relapsed/Refractory Follicular Lymphoma (FL)
Published: 2023-12-09 (Crawled : 20:20) - globenewswire.com
GMAB | $28.33 -0.7% -0.74% 360
|
Health Technology
| Email alert
Add to watchlist
GNMSF | $290.38 3.33% 3.83% 0
|
Health Technology
| Email alert
Add to watchlist
ABBV | News | $164.66 0.25% -0.55% 0
|
Health Technology
| Email alert
Add to watchlist
cd20 duobody antibody
Alvotech Reports Financial Results for First Nine Months of 2023 and Provides Business Update
Published: 2023-11-28 (Crawled : 21:00) - globenewswire.com
ALVO | $12.89 0.7% 0.78% 220
|
n/a
|
| O: 1.02%
H: 0.0%
C: -5.05%
NVS | $92.57 -0.55% 0.51% 0
|
Health Technology
|
| O: 0.18%
H: 0.12%
C: -0.16%
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
ABBV | News | $164.66 0.25% -0.55% 0
|
Health Technology
|
| O: -0.73%
H: 0.78%
C: 0.35%
KMDA | $5.1 0.39% -0.1% 6.5K
|
Health Technology
|
| O: 0.73%
H: 0.0%
C: -1.04%
business update financial results
Alvotech Reports Financial Results for First Nine Months of 2023 and Provides a Business Update
Published: 2023-11-28 (Crawled : 21:00) - globenewswire.com
ALVO | $12.89 0.7% 0.78% 220
|
n/a
|
| O: 1.02%
H: 0.0%
C: -5.05%
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
ABBV | News | $164.66 0.25% -0.55% 0
|
Health Technology
|
| O: -0.73%
H: 0.78%
C: 0.35%
KMDA | $5.1 0.39% -0.1% 6.5K
|
Health Technology
|
| O: 0.73%
H: 0.0%
C: -1.04%
business update financial results
NEXGEL Reports Record Third Quarter 2023 Revenue of $1.2 Million, an Increase of 115% Year-Over-Year
Published: 2023-11-13 (Crawled : 21:00) - globenewswire.com
NXGL | News | $2.21 -2.0% -1.4% 1.1K
|
Manufacturing
|
| O: 7.39%
H: 1.06%
C: -5.29%
ABBV | News | $164.66 0.25% -0.55% 0
|
Health Technology
|
| O: 0.47%
H: 0.0%
C: 0.0%
revenue
Genmab Announces Financial Results for the First Nine Months of 2023
Published: 2023-11-07 (Crawled : 16:00) - globenewswire.com
GNMSF | $290.38 3.33% 3.83% 0
|
Health Technology
|
| O: 0.39%
H: 4.92%
C: 1.52%
NVS | $92.57 -0.55% 0.51% 0
|
Health Technology
|
| O: 0.24%
H: 0.18%
C: 0.16%
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: 0.18%
H: 0.0%
C: 0.0%
ABBV | News | $164.66 0.25% -0.55% 0
|
Health Technology
|
| O: -0.28%
H: 0.0%
C: 0.0%
GMAB | $28.33 -0.7% -0.74% 360
|
Health Technology
|
| O: 0.24%
H: 3.44%
C: 2.07%
BNTX | $86.17 -0.27% -0.24% 2.2K
|
Health Technology
|
| O: -0.35%
H: 3.09%
C: 3.03%
financial results
Coherus BioSciences Reports Third Quarter 2023 Financial Results and Business Highlights
Published: 2023-11-06 (Crawled : 21:00) - globenewswire.com
ABBV | News | $164.66 0.25% -0.55% 0
|
Health Technology
|
| O: -0.28%
H: 0.0%
C: 0.0%
CHRS | $2.0 -6.98% -8.04% 3.5K
|
Health Technology
|
| O: -22.6%
H: 3.28%
C: -9.85%
business financial results
NEXGEL Secures Supply Agreement with AbbVie
Published: 2023-10-30 (Crawled : 12:00) - globenewswire.com
NXGL | News | $2.21 -2.0% -1.4% 1.1K
|
Manufacturing
|
| O: 5.0%
H: 12.49%
C: -4.76%
ABBV | News | $164.66 0.25% -0.55% 0
|
Health Technology
|
| O: 2.87%
H: 0.0%
C: 0.0%
abbvie agreement
Alector Announces Completion of Enrollment in the INVOKE-2 Phase 2 Clinical Trial of AL002, a TREM2 Monoclonal Antibody, in Individuals With Early Alzheimer’s Disease
Published: 2023-09-07 (Crawled : 11:00) - globenewswire.com
ABBV | News | $164.66 0.25% -0.55% 0
|
Health Technology
|
| O: 0.13%
H: 1.95%
C: 1.89%
ALEC | $5.09 0.39% 0.59% 410K
|
Health Technology
|
| O: -1.24%
H: 10.79%
C: 8.09%
al002 disease alzheimer’s trial
Alvotech Reports Financial Results for First Six Months of 2023 and Provides Business Update
Published: 2023-08-30 (Crawled : 20:00) - globenewswire.com
ALVO | $12.89 0.7% 0.78% 220
|
n/a
|
| O: 0.21%
H: 3.28%
C: 1.54%
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: -1.35%
H: 0.12%
C: -1.03%
ABBV | News | $164.66 0.25% -0.55% 0
|
Health Technology
|
| O: 0.16%
H: 0.0%
C: 0.0%
KMDA | $5.1 0.39% -0.1% 6.5K
|
Health Technology
|
| O: 1.24%
H: 1.23%
C: 0.88%
AMGN | $262.75 -0.5% -0.49% 320
|
Health Technology
|
| O: 0.13%
H: 0.3%
C: -0.73%
six business update financial results
Sight Sciences Reports Second Quarter 2023 Financial Results and Reaffirms Guidance for Full Year 2023
Published: 2023-08-03 (Crawled : 20:00) - globenewswire.com
SGHT | News | $5.24 -2.6% -1.7% 550
|
|
| O: 0.62%
H: 10.26%
C: 6.92%
ABBV | News | $164.66 0.25% -0.55% 0
|
Health Technology
|
| O: -0.05%
H: 1.07%
C: -0.83%
year sciences financial results
Genmab Announces Financial Results for the First Half of 2023
Published: 2023-08-03 (Crawled : 15:00) - globenewswire.com
GNMSF | $290.38 3.33% 3.83% 0
|
Health Technology
|
| O: 0.24%
H: 1.29%
C: 1.29%
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: 0.66%
H: 0.0%
C: 0.0%
ABBV | News | $164.66 0.25% -0.55% 0
|
Health Technology
|
| O: -0.28%
H: 0.27%
C: 0.06%
GMAB | $28.33 -0.7% -0.74% 360
|
Health Technology
|
| O: -2.25%
H: 1.87%
C: 1.52%
BNTX | $86.17 -0.27% -0.24% 2.2K
|
Health Technology
|
| O: -0.25%
H: 3.13%
C: 1.84%
financial results
Coherus BioSciences Reports Second Quarter 2023 Financial Results and Business Highlights
Published: 2023-08-02 (Crawled : 20:00) - globenewswire.com
ABBV | News | $164.66 0.25% -0.55% 0
|
Health Technology
|
| O: -0.28%
H: 0.27%
C: 0.06%
SURF | $1.07 -0.93% -1.41% 0
|
Health Technology
|
| O: 3.49%
H: 14.13%
C: 10.87%
CHRS | $2.0 -6.98% -8.04% 3.5K
|
Health Technology
|
| O: 9.45%
H: 10.53%
C: 7.58%
business financial results
Invivyd Announces Appointment of Sara Cotter to Board Of Directors
Published: 2023-07-27 (Crawled : 20:00) - globenewswire.com
IVVD | $2.35 -5.24% -4.86% 480K
|
Manufacturing
|
| O: -0.69%
H: 4.17%
C: 0.0%
ABBV | News | $164.66 0.25% -0.55% 0
|
Health Technology
|
| O: 0.72%
H: 1.23%
C: 0.62%
ABT | News | $105.27 -0.6% -0.38% 5.9M
|
Health Technology
|
| O: -1.09%
H: 0.3%
C: -0.4%
Cabaletta Bio Appoints Global Commercial Leader Shawn Tomasello to Board of Directors
Published: 2023-07-24 (Crawled : 12:00) - globenewswire.com
ABBV | News | $164.66 0.25% -0.55% 0
|
Health Technology
|
| O: 0.48%
H: 0.0%
C: 0.0%
GILD | News | $66.16 -1.15% -1.16% 1.4K
|
Health Technology
|
| O: -1.02%
H: 0.45%
C: -2.71%
CABA | $13.97 -7.79% -8.52% 0
|
Health Technology
|
| O: -0.22%
H: 0.45%
C: -6.47%
global commercial
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
ZCMD | $1.45 5.84% 49.63% 15M
|
Commercial Services
AULT | $0.2421 -7.7% 45.23% 16M
|
Manufacturing
XPON | News | $3.15 63.21% 33.9% 100K
|
EGOX | $0.036 12.15% 31.56% 32M
|
TIRX | $0.8 65.02% 25.95% 410K
|
VTNR 4 | $1.31 33.78% 25.82% 220K
|
Industrial Services
GDHG | $0.263 21.76% 25.34% 1.3M
|
TPET | $0.3279 -3.56% 23.57% 11M
|
n/a
HOLO | $2.95 31.7% 22.49% 37M
|
MTNB | $0.19 -1.04% 14.58% 950K
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.